Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-041383
Filing Date
2025-03-18
Accepted
2025-03-18 17:04:51
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 8649
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 71904
3 EX-99.A ck0001669811-ex99_a.pdf EX-99.A 143472
4 EX-99.B ck0001669811-ex99_b.pdf EX-99.B 61887
  Complete submission text file 0000950170-25-041383.txt   393260
Mailing Address BREITNER CENTER AMSTELPLEIN 2 AMSTERDAM P7 1096 BC
Business Address BREITNER CENTER AMSTELPLEIN 2 AMSTERDAM P7 1096 BC 31 20 59 77777
KONINKLIJKE PHILIPS NV (Subject) CIK: 0000313216 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-81501 | Film No.: 25749373
SIC: 3844 X-Ray Apparatus & Tubes & Related Irradiation Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address SYMPHONY BUILDING GUSTAV MAHLERPLEIN 25 AMSTERDAM P7 1082 MS
Business Address SYMPHONY BUILDING GUSTAV MAHLERPLEIN 25 AMSTERDAM P7 1082 MS 390115090345
Exor N.V. (Filed by) CIK: 0001589122 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A